QS Investors, LLC - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 151 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$95,000
-52.3%
4,000
-45.9%
0.00%
-50.0%
Q3 2019$199,000
-1.0%
7,4000.0%0.00%0.0%
Q2 2019$201,000
+191.3%
7,400
+184.6%
0.00%
+100.0%
Q3 2018$69,000
-30.3%
2,600
-0.4%
0.00%0.0%
Q2 2018$99,000
+16.5%
2,6110.0%0.00%0.0%
Q1 2018$85,000
-33.1%
2,6110.0%0.00%0.0%
Q4 2017$127,000
-9.9%
2,6110.0%0.00%0.0%
Q3 2017$141,000
-4.1%
2,6110.0%0.00%0.0%
Q2 2017$147,000
+14600.0%
2,611
+23636.4%
0.00%
Q2 2016$1,0000.0%11
-50.0%
0.00%
Q1 2016$1,0000.0%22
+266.7%
0.00%
Q4 2015$1,00060.00%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 232,952$5,498,0005.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,673,727$86,700,0003.41%
Redmile Group, LLC 1,466,537$34,610,0003.31%
SECTORAL ASSET MANAGEMENT INC 1,229,382$29,013,0003.00%
HARVEY CAPITAL MANAGEMENT INC 206,530$4,874,0002.44%
Marcus Capital, LLC 75,150$1,774,0001.87%
Cormorant Asset Management, LP 396,000$9,346,0001.32%
Rail-Splitter Capital Management, LLC 221,414$5,225,0001.25%
Temasek Holdings (Private) Ltd 6,583,568$155,372,0001.21%
EMERALD MUTUAL FUND ADVISERS TRUST 636,526$15,022,0000.84%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders